Mothercare Plc : Holding(s) in Company For

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
64
Mothercare Plc : Holding(s) in Company
For filings with the FSA include the annex  
For filings with issuer exclude the annex  
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
   
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Mothercare Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  
An event changing the breakdown of voting rights  
Other (please specify):    
3. Full name of person(s) subject to the notification obligation: iii Richard Griffiths and controlled undertakings
4. Full name of shareholder(s)  (if different from 3.):iv  
5. Date of the transaction and date on which the threshold is crossed or reached: v 17 March 2017
6. Date on which issuer notified: 21 March 2017
7. Threshold(s) that is/are crossed or reached: vi, vii > 3,4%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE Situation previous to the triggering transaction Resulting situation after the triggering transaction
Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
  Ordinary GB0009067447 < 3% < 3% 1,214,271 1,214,271   0.71%  
 
 
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date xiii Exercise/ Conversion Period xiv Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
CFD     6,164,719 3.61%
 
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date xvii Exercise/ Conversion period xviii Number of voting rights instrument refers to   % of voting rights xix, xx  
            Nominal Delta
   
 
Total (A+B+C)
Number of voting rights Percentage of voting rights
7,378,990 4.32%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Seren Investment Management Limited 1,178,271
Oak Trust Limited 36,000
  1,214,271
QFI's  
CFD - Richard Griffiths 6,164,719
Total 7,378,990

The above entities are controlled by Richard Griffiths

Proxy Voting: 10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name: James Sutcliffe 15. Contact telephone number: +44 1534 719761

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
 
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)    
Contact address (registered office for legal entities)    
Phone number & email    
Other useful information (at least legal representative for legal persons)    
   
B: Identity of the notifier, if applicable
Full name    
Contact address    
Phone number & email    
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)  
 
C: Additional information
 
For notes on how to complete form TR-1 please see the FSA website.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

XPENG Delivers 39,107 Vehicles in August 2026

Updated Category News Views 11

Grit and Green in XPENG's Latest Numbers You'd think someone at XPENG's HQ popped the champagne today, given what they're reporting, but don't let the buzz fool you. August 2026 saw them deliver 39,107 vehicles. That's a nice 4% tick up year over year. But remember, we're talking a sector where anything short of double digits can feel like a whisper instead of a roar....

Continue Reading
Artivion Set to Announce Financial Results in February 2026

Updated Category News Views 90

Artivion to Announce Fourth Quarter Financial Results Artivion, Inc. (NYSE: AORT), a renowned company in the cardiac and vascular sector, has set a date for the release of its fourth quarter financial results for the year 2025. The main announcement will occur on the afternoon of the market closing on February 12, 2026. This release is highly anticipated within investor...

Continue Reading
FibroBiologics and Charles River Unite for Cell Therapy Advancements

Updated Category News Views 181

FibroBiologics Partners with Charles River for Innovative Therapies FibroBiologics, Inc. (Nasdaq: FBLG), a pioneering biotechnology company, has announced a groundbreaking collaboration with Charles River Laboratories, a renowned name in drug discovery and manufacturing. This partnership aims to develop and manufacture advanced fibroblast cell-based therapies intended to...

Continue Reading
Axsome Therapeutics Looks Ahead with Participations in Events

Updated Category News Views 128

Axsome Therapeutics: Engaging the Investment Community Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical enterprise focused on revolutionary treatments for central nervous system (CNS) disorders, has exciting plans ahead as it prepares to engage with investors at significant upcoming conferences. This engagement highlights the company's commitment...

Continue Reading
Palmstreet's Bold Moves in the $68B Live Shopping Boom

Updated Category News Views 9

Palmstreet Sets the Stage for Seller Success As the live shopping phenomenon in the U.S. rivals the busiest stock market scramble, Palmstreet is laying down some serious game-changing strategies. We're staring at a market expected to hit a staggering $68 billion in 2026, more than doubling its size from three years ago. Instead of riding the coattails of this lucrative...

Continue Reading